Why are patient registries so important for future trials?

Clinical trials for rare diseases can only happen if researchers and companies can quickly identify eligible patients. Registries make this possible. In a disease as rare as LAMA2-RD, every patient who joins a registry is making a direct contribution to making trials happen. If you are not sure where to start, contact us and we can help direct you.